行情

BEAT

BEAT

生物遥测公司
NASDAQ

实时行情|Nasdaq Last Sale

35.15
-3.36
-8.73%
盘后: 35.15 0 0.00% 16:46 04/01 EDT
开盘
36.61
昨收
38.51
最高
37.68
最低
31.24
成交量
46.20万
成交额
--
52周最高
63.24
52周最低
27.35
市值
11.98亿
市盈率(TTM)
42.80
分时
5日
1月
3月
1年
5年

分析师评级

6位分析师的综合评级

买入

免责声明:分析师观点仅供投资者决策参考,不构成任何买卖投资建议。

目标价格预测

分析师预测BEAT价格均价为63.00,最高价位80.00,最低价为54.00。

EPS

BEAT 新闻

更多
  • 全球避孕套告急!泰国最大生产商达到产能极限
  • 新浪财经 · 56分钟前
  • 油价大涨 伦敦布伦特油价涨幅扩大至近13%
  • 新浪财经 · 1小时前
  • 美服装巨头PVH的老板戏剧性确诊感染新冠:无症状
  • 新浪财经 · 1小时前
  • 高盛:垃圾债最坏的日子尚未到来 违约势将增加
  • 新浪财经 · 1小时前

所属板块

医疗设施与服务
-3.84%
医疗保健提供商与服务
-4.36%

热门股票

代码
价格
涨跌幅

BEAT 简况

BioTelemetry, Inc. provides monitoring services and digital population health management in a healthcare setting, medical device manufacturing and centralized laboratory services for clinical research. The Company operates in three segments: Healthcare, Technology and Research. The Healthcare segment, operating as CardioNet, LLC and Heartcare Corporation of America, Inc., is focused on the diagnosis and monitoring of cardiac arrhythmias, or heart rhythm disorders. The Research segment, operating as Cardiocore, LLC and VirtualScopics, Inc., is engaged in laboratory services that provide cardiac monitoring, imaging services, scientific consulting and data management services for drug, medical treatment and device trials. The Technology segment, operating as Braemar Manufacturing, LLC, Universal Medical, Inc. and BioTelemetry Belgium BVBA. and BioTelemetry Technology ApS, focuses on the manufacturing, engineering and development of noninvasive cardiac monitors for healthcare companies.
展开

微牛提供BioTelemetry Inc(NASDAQ-BEAT)的股票价格,实时市场报价,专业分析师评级,深度图表和免费的BEAT股票新闻,以帮助您做出投资决策。